Trial Profile
A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan UD Monotherapy for Medical Reasons
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary)
- Indications Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Allergan
- 08 May 2014 New trial record